Mitochondrial dysfunction and mitophagy in Parkinson’s disease: From mechanism to therapy

Mitochondrial dysfunction and mitophagy in Parkinson’s disease: From mechanism to therapy

Mitochondrial dysfunction is implicated in PD through both environmental exposure and genetic factors. Increased understanding of mitochondrial dysfunction and mitophagy in PD has identified new mechanisms and therapeutic opportunities. Identification of the up- and downstream regulators of PINK1/pa...

Bibliografiset tiedot
Päätekijät:	Malpartida, AB, Williamson, M, Narendra, DP, Wade-Martins, R, Ryan, BJ
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	Cell Press 2020

Samankaltaisia teoksia

Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease.
Tekijä: Ryan, B, et al.
Julkaistu: (2015)

Modulating mitophagy in mitochondrial disease.
Tekijä: Dombi, E, et al.
Julkaistu: (2017)

Detecting mitophagy in mitochondrial disease: towards a new type of therapy
Tekijä: Dombi, E
Julkaistu: (2019)

The role of astrocyte dysfunction in Parkinson's disease pathogenesis
Tekijä: Booth, H, et al.
Julkaistu: (2017)

Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells
Tekijä: Smith, A, et al.
Julkaistu: (2018)

Mitophagy plays a central role in mitochondrial ageing
Tekijä: Diot, A, et al.
Julkaistu: (2016)

Mitochondrial dysfunction and Parkinson’s disease — near-infrared photobiomodulation as a potential therapeutic strategy
Tekijä: Foo, Aaron Song Chuan, et al.
Julkaistu: (2021)

Oculomotor Dysfunction in Parkinson's Disease
Tekijä: Kennard, C, et al.
Julkaistu: (2013)

Oculomotor Dysfunction in Parkinson's Disease
Tekijä: Kennard, C, et al.
Julkaistu: (2013)

Targeting alpha-synuclein as a therapy for Parkinson’s disease
Tekijä: Fields, CR, et al.
Julkaistu: (2019)

α-Synuclein and mitochondrial bioenergetics regulate tetrahydrobiopterin levels in a human dopaminergic model of Parkinson disease.
Tekijä: Ryan, B, et al.
Julkaistu: (2014)

Mitophagy Transcriptome: Mechanistic Insights into Polyphenol-Mediated Mitophagy
Tekijä: Tan, Sijie, et al.
Julkaistu: (2017)

Investigating the effects of autophagic perturbations on mitochondrial function in Parkinson’s Disease
Tekijä: Ryan Barlow Patterson
Julkaistu: (2019)

The role of mitophagy during oocyte aging in human, mouse, and Drosophila: implications for oocyte quality and mitochondrial disease
Tekijä: Cox, RT, et al.
Julkaistu: (2021)

Mitochondrial dysfunction in Down Syndrome: from pathology to therapy
Tekijä: Tan, Kai-Leng, et al.
Julkaistu: (2023)

Dysregulated mitophagy and mitochondrial organization in optic atrophy due to OPA1 mutations.
Tekijä: Liao, C, et al.
Julkaistu: (2016)

Convergent pathways in Parkinson’s disease
Tekijä: Cherubini, M, et al.
Julkaistu: (2017)

Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.
Tekijä: Ryan, B, et al.
Julkaistu: (2014)

S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson’s Disease Models
Tekijä: Oh, Chang-Ki, et al.
Julkaistu: (2018)

Dysregulated mitophagy and mitochondrial transport in severe dominant optic atrophy due to OPA1 mutations
Tekijä: Liao, C, et al.
Julkaistu: (2012)

Dysregulated mitophagy and mitochondrial transport in severe inherited optic atrophy due to OPA1 mutations
Tekijä: Poulton, J, et al.
Julkaistu: (2012)

Compounds from an Unbiased Chemical Screen Reverse Both Er-to-Golgi Trafficking Defects and Mitochondrial Dysfunction in Parkinson's Disease Models
Tekijä: Su, Linhui Julie, et al.
Julkaistu: (2011)

Are rodent models of Parkinson's disease behaving as they should?
Tekijä: Vingill, S, et al.
Julkaistu: (2017)

The m.13051G>A mitochondrial DNA mutation results in variable neurology and activated mitophagy
Tekijä: Poulton, J, et al.
Julkaistu: (2016)

Restorative therapies in Parkinsons disease /
Tekijä: Brundin, Patrik, et al.
Julkaistu: (2006)

Parkinson disease, LRRK2 and the endocytic-autophagic pathway.
Tekijä: Alegre-Abarrategui, J, et al.
Julkaistu: (2009)

α-Synuclein and dopamine at the crossroads of Parkinson's disease.
Tekijä: Venda, L, et al.
Julkaistu: (2010)

Cortical structural involvement and cognitive dysfunction in early Parkinson's disease
Tekijä: Klein, J, et al.
Julkaistu: (2018)

Role of mitophagy in muscle growth and metabolism
Tekijä: Peker, Nesibe
Julkaistu: (2017)

Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons
Tekijä: Zambon, F, et al.
Julkaistu: (2019)

Hypoxia as a therapy for mitochondrial disease
Tekijä: Jain, I. H., et al.
Julkaistu: (2017)

Commentary: Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models
Tekijä: Fernandes, H, et al.
Julkaistu: (2017)

Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer’s disease
Tekijä: Park, Jung Eun, et al.
Julkaistu: (2019)

UNDERSTANDING THE EARLY PATHOLOGICAL PATHWAYS IN PARKINSON'S DISEASE. THE OXFORD PARKINSON'S DISEASE CENTRE
Tekijä: Hu, M, et al.
Julkaistu: (2010)

Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer’s disease with cerebrovascular disease
Tekijä: Gallart-Palau, Xavier, et al.
Julkaistu: (2018)

Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model.
Tekijä: Janezic, S, et al.
Julkaistu: (2013)

What is our understanding of the influence of gut microbiota on the pathophysiology of Parkinson’s disease?
Tekijä: Hill, A, et al.
Julkaistu: (2021)

Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and CSF
Tekijä: Winchester, L, et al.
Julkaistu: (2022)

Oxygen, the invisible orchestrator of metabolism and disease : a focus on mitochondrial And peroxisomal dysfunction
Tekijä: Jain, Isha Himani
Julkaistu: (2018)

Pathological features of mitochondrial respiratory chain dysfunction
Tekijä: Chen, Walter W
Julkaistu: (2016)